Spots Global Cancer Trial Database for endostatin
Every month we try and update this database with for endostatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor | NCT01845675 | Advanced Well-d... | temozolomide or... | 18 Years - | Peking Union Medical College Hospital | |
Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. | NCT02745561 | Esophageal Canc... Endostatin | Endostatins Oxaliplatin Radiotherapy | 18 Years - 80 Years | Hangzhou Cancer Hospital | |
Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | NCT02104323 | Vestibular Schw... Neurofibromatos... | Endostatin | 16 Years - 30 Years | Beijing Tiantan Hospital | |
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma | NCT01612286 | Nasopharyngeal ... | endostatin | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer | NCT05385185 | Leptomeningeal ... Immune Checkpoi... Endostatin | Camrelizumab or... | 18 Years - | Hebei Medical University | |
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma | NCT03932266 | Nasopharyngeal ... | Endostar Cisplatin Docetaxel Intensity Modul... | 18 Years - 70 Years | Jiangsu Cancer Institute & Hospital | |
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer | NCT00604435 | Breast Cancer | docetaxel and e... docetaxel and e... | 18 Years - 70 Years | Xijing Hospital | |
Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor | NCT01260025 | Tolerability Pharmacokinetic... Endostatin | PEDylated Recom... | 18 Years - 65 Years | Sun Yat-sen University | |
Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
Radiotherapy Combined With Endostatin and Capecitabine for NPC | NCT05514275 | Nasopharyngeal ... | Endostatin and ... | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
Nab-PCE vs PC for MM After Failure of Anti-PD-1 | NCT03917069 | Advanced Melano... | Chemotherapeuti... chemotherapy | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma | NCT01612286 | Nasopharyngeal ... | endostatin | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer | NCT00604435 | Breast Cancer | docetaxel and e... docetaxel and e... | 18 Years - 70 Years | Xijing Hospital | |
Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor | NCT01260025 | Tolerability Pharmacokinetic... Endostatin | PEDylated Recom... | 18 Years - 65 Years | Sun Yat-sen University | |
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma | NCT03932266 | Nasopharyngeal ... | Endostar Cisplatin Docetaxel Intensity Modul... | 18 Years - 70 Years | Jiangsu Cancer Institute & Hospital | |
Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer | NCT01218594 | Non-small Cell ... | Endostatin | 18 Years - 75 Years | Sun Yat-sen University | |
Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor | NCT01845675 | Advanced Well-d... | temozolomide or... | 18 Years - | Peking Union Medical College Hospital | |
Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor | NCT00262327 | Advanced Solid ... | Antangiogenesis endostatin gene | 18 Years - 65 Years | Sun Yat-sen University | |
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC | NCT02497118 | Non Small Cell ... | Endostatin Vinorelbine Cisplatin | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. | NCT02745561 | Esophageal Canc... Endostatin | Endostatins Oxaliplatin Radiotherapy | 18 Years - 80 Years | Hangzhou Cancer Hospital |